Literature DB >> 19433059

PKCtheta is required for hemostasis and positive regulation of thrombin-induced platelet aggregation and alpha-granule secretion.

Sagit Cohen1, Alex Braiman, George Shubinsky, Ariel Ohayon, Amnon Altman, Noah Isakov.   

Abstract

Platelet activation due to vascular injury is essential for hemostatic plug formation, and is mediated by agonists, such as thrombin, which trigger distinct receptor-coupled signaling pathways. Thrombin is a coagulation protease, which activates G protein-coupled protease-activated receptors (PARs) on the surface of platelets. We found that C57BL/6J and BALB/C mice that are deficient in protein kinase C theta (PKCtheta), exhibit an impaired hemostasis, and prolonged bleeding following vascular injury. In addition, murine platelets deficient in PKCtheta displayed an impaired thrombin-induced platelet activation and aggregation response. Lack of PKCtheta also resulted in impaired alpha-granule secretion, as demonstrated by the low surface expression of CD62P, in thrombin-stimulated platelets. Since PAR4 is the only mouse PAR receptor that delivers thrombin-induced activation signals in platelets, our results suggest that PKCtheta is a critical effector molecule in the PAR4-linked signaling pathways and in the regulation of normal hemostasis in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433059     DOI: 10.1016/j.bbrc.2009.05.021

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Therapeutic potential for protein kinase C inhibitor in vascular restenosis.

Authors:  Richard Qinxue Ding; Jerry Tsao; Hong Chai; Daria Mochly-Rosen; Wei Zhou
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-12-23       Impact factor: 2.457

2.  Protein kinase Cδ mediates the activation of protein kinase D2 in platelets.

Authors:  Dheeraj Bhavanasi; Soochong Kim; Lawrence E Goldfinger; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

3.  Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.

Authors:  Gauthami Jalagadugula; Guangfen Mao; Gurpreet Kaur; Danny N Dhanasekaran; A Koneti Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-20       Impact factor: 8.311

4.  The Src family kinases and protein kinase C synergize to mediate Gq-dependent platelet activation.

Authors:  Binggang Xiang; Guoying Zhang; Lucia Stefanini; Wolfgang Bergmeier; T Kent Gartner; Sidney W Whiteheart; Zhenyu Li
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

5.  Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen.

Authors:  Karen Gilio; Matthew T Harper; Judith M E M Cosemans; Olga Konopatskaya; Imke C A Munnix; Lenneke Prinzen; Michael Leitges; Qinghang Liu; Jeffery D Molkentin; Johan W M Heemskerk; Alastair W Poole
Journal:  J Biol Chem       Date:  2010-05-17       Impact factor: 5.157

6.  mTOR regulates GPVI-mediated platelet activation.

Authors:  Longsheng Wang; Gang Liu; Nannan Wu; Baiyun Dai; Shuang Han; Qiaoyun Liu; Fang Huang; Zhihua Chen; Weihong Xu; Dajing Xia; Cunji Gao
Journal:  J Transl Med       Date:  2021-05-10       Impact factor: 5.531

7.  Protein kinase Cε and protein kinase Cθ double-deficient mice have a bleeding diathesis.

Authors:  A J Unsworth; B A Finney; L Navarro-Nunez; S Severin; S P Watson; C J Pears
Journal:  J Thromb Haemost       Date:  2012-09       Impact factor: 5.824

8.  PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors.

Authors:  Noah Isakov; Amnon Altman
Journal:  Front Immunol       Date:  2012-08-22       Impact factor: 7.561

9.  Smoking affects gene expression in blood of patients with ischemic stroke.

Authors:  Xiyuan Cheng; Eva Ferino; Heather Hull; Glen C Jickling; Bradley P Ander; Boryana Stamova; Frank R Sharp
Journal:  Ann Clin Transl Neurol       Date:  2019-08-22       Impact factor: 4.511

10.  Integrin αIIbβ3 outside-in signaling activates human platelets through serine 24 phosphorylation of Disabled-2.

Authors:  Hui-Ju Tsai; Ju-Chien Cheng; Man-Leng Kao; Hung-Pin Chiu; Yi-Hsuan Chiang; Ding-Ping Chen; Kun-Ming Rau; Hsiang-Ruei Liao; Ching-Ping Tseng
Journal:  Cell Biosci       Date:  2021-02-08       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.